http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SI-3419598-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00ca6f00ac12fd683f21da5d20c6d349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5270fe656bc80c670b4e3e83590e0d57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56262e82e60ea99a6ed6fba023929546
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-1468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-1412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0029
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
filingDate 2017-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e2978d5bb363e3d17024bdb6a7349e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_975ecab98e74c49267c96db6009cc0a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df1644244bdf679dbdd1008e076a1525
publicationDate 2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SI-3419598-T1
titleOfInvention Phosphomycin formulation for parenteral administration
priorityDate 2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494095

Total number of triples: 28.